A Convenient Chemoenzymatic Preparation of Chimeric Macrocyclic Peptide Antibiotics with Potent Activity against Gram-Negative Pathogens.
Thomas M WoodCornelis J SlingerlandNathaniel I MartinPublished in: Journal of medicinal chemistry (2021)
The continuing rise of antibiotic resistance, particularly among Gram-negative pathogens, threatens to undermine many aspects of modern medical practice. To address this threat, novel antibiotics that utilize unexploited bacterial targets are urgently needed. Over the past decade, a number of studies have highlighted the antibacterial potential of macrocyclic peptides that target Gram-negative outer membrane proteins (OMPs). Recently, it was reported that the antibacterial activities of OMP-targeting macrocyclic peptidomimetics of the antimicrobial peptide protegrin-1 are dramatically enhanced upon linking to polymyxin E nonapeptide (PMEN). In this study, we describe a convergent, chemoenzymatic route for the convenient preparation of such conjugates. Specifically, we investigated the use of both amide bond formation and azide-alkyne ligation for connecting an OMP-targeting macrocyclic peptide to a PMEN building block (obtained by enzymatic degradation of polymyxin E). The conjugates obtained via both approaches display potent antibacterial activity against a range of Gram-negative pathogens including multi-drug-resistant isolates.
Keyphrases
- gram negative
- multidrug resistant
- drug resistant
- acinetobacter baumannii
- cancer therapy
- healthcare
- silver nanoparticles
- anti inflammatory
- primary care
- cell therapy
- stem cells
- drug delivery
- molecularly imprinted
- nitric oxide
- mass spectrometry
- mesenchymal stem cells
- pseudomonas aeruginosa
- essential oil
- case control
- wound healing
- transition metal